Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Correction to Antileishmanial Activity of a Series of N(2),N(4)-Disubstituted Quinazoline-2,4-diamines.

Van Horn KS, Zhu X, Pandharkar T, Yang S, Vesely B, Vanaerschot M, Dujardin JC, Rijal S, Kyle DE, Wang MZ, Werbovetz KA, Manetsch R.

J Med Chem. 2016 Jan 28;59(2):775. doi: 10.1021/acs.jmedchem.5b00981. Epub 2016 Jan 12. No abstract available.

PMID:
26754204
2.

SAR refinement of antileishmanial N(2),N(4)-disubstituted quinazoline-2,4-diamines.

Zhu X, Van Horn KS, Barber MM, Yang S, Wang MZ, Manetsch R, Werbovetz KA.

Bioorg Med Chem. 2015 Aug 15;23(16):5182-9. doi: 10.1016/j.bmc.2015.02.020. Epub 2015 Feb 18.

3.

Body composition and mortality after adult lung transplantation in the United States.

Singer JP, Peterson ER, Snyder ME, Katz PP, Golden JA, D'Ovidio F, Bacchetta M, Sonett JR, Kukreja J, Shah L, Robbins H, Van Horn K, Shah RJ, Diamond JM, Wickersham N, Sun L, Hays S, Arcasoy SM, Palmer SM, Ware LB, Christie JD, Lederer DJ.

Am J Respir Crit Care Med. 2014 Nov 1;190(9):1012-21. doi: 10.1164/rccm.201405-0973OC.

4.

Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.

Knip M, Åkerblom HK, Becker D, Dosch HM, Dupre J, Fraser W, Howard N, Ilonen J, Krischer JP, Kordonouri O, Lawson ML, Palmer JP, Savilahti E, Vaarala O, Virtanen SM; TRIGR Study Group.

JAMA. 2014 Jun 11;311(22):2279-87. doi: 10.1001/jama.2014.5610.

5.

Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines.

Van Horn KS, Zhu X, Pandharkar T, Yang S, Vesely B, Vanaerschot M, Dujardin JC, Rijal S, Kyle DE, Wang MZ, Werbovetz KA, Manetsch R.

J Med Chem. 2014 Jun 26;57(12):5141-56. doi: 10.1021/jm5000408. Epub 2014 Jun 17.

6.

Personality risk for alcohol consequences among college freshmen.

Kazemi DM, Flowers C, Shou Q, Levine MJ, Van Horn KR.

J Psychosoc Nurs Ment Health Serv. 2014 Jul;52(7):38-45. doi: 10.3928/02793695-20140310-01. Epub 2014 Mar 18.

PMID:
24627978
7.

Antibacterial activity of a series of N2,N4-disubstituted quinazoline-2,4-diamines.

Van Horn KS, Burda WN, Fleeman R, Shaw LN, Manetsch R.

J Med Chem. 2014 Apr 10;57(7):3075-93. doi: 10.1021/jm500039e. Epub 2014 Mar 31.

PMID:
24625106
8.

Growth differences between North American and European children at risk for type 1 diabetes.

Nucci AM, Becker DJ, Virtanen SM, Cuthbertson D, Softness B, Huot C, Wasikowa R, Dosch HM, Akerblom HK, Knip M; TRIGR Study Group.

Pediatr Diabetes. 2012 Aug;13(5):425-31. doi: 10.1111/j.1399-5448.2011.00840.x. Epub 2012 Jan 17.

9.

Cultural differences in asymmetric beliefs of interpersonal knowledge in vertical and horizontal relationships.

Cho Y, Otani H, Han K, Van Horn KR.

J Gen Psychol. 2010 Oct-Dec;137(4):343-61. doi: 10.1080/00221309.2010.499396.

PMID:
21086857
10.

Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.

Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Barton R, Bijie H, Bille J, Chang SC, da Luz Martins M, Duse A, Dzierzanowska D, Ellis D, Finquelievich J, Gould I, Gur D, Hoosen A, Lee K, Mallatova N, Mallie M, Peng NG, Petrikos G, Santiago A, Trupl J, VanDen Abeele AM, Wadula J, Zaidi M; Global Antifungal Surveillance Group.

Diagn Microbiol Infect Dis. 2010 Jun;67(2):162-71. doi: 10.1016/j.diagmicrobio.2010.01.002. Epub 2010 Mar 24.

PMID:
20338711
11.

Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.

Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ; ARTEMIS DISK Global Antifungal Surveillance Group.

Diagn Microbiol Infect Dis. 2009 Sep;65(1):27-34. doi: 10.1016/j.diagmicrobio.2009.05.007.

PMID:
19679232
12.

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.

Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Bijie H, Dzierzanowska D, Klimko NN, Letscher-Bru V, Lisalova M, Muehlethaler K, Rennison C, Zaidi M; Global Antifungal Surveillance Group.

J Clin Microbiol. 2009 Jan;47(1):117-23. doi: 10.1128/JCM.01747-08. Epub 2008 Nov 12.

13.

Comparison of 3 swab transport systems for direct release and recovery of aerobic and anaerobic bacteria.

Van Horn KG, Audette CD, Tucker KA, Sebeck D.

Diagn Microbiol Infect Dis. 2008 Dec;62(4):471-3. doi: 10.1016/j.diagmicrobio.2008.08.004. Epub 2008 Sep 23.

PMID:
18814991
14.

Comparison of the Copan ESwab system with two Amies agar swab transport systems for maintenance of microorganism viability.

Van Horn KG, Audette CD, Sebeck D, Tucker KA.

J Clin Microbiol. 2008 May;46(5):1655-8. doi: 10.1128/JCM.02047-07. Epub 2008 Mar 19.

15.

Identification of interferon-beta antibodies in a reference laboratory setting: findings for 1144 consecutive sera.

Prince HE, Lapé-Nixon M, Audette C, Van Horn K.

J Neuroimmunol. 2007 Oct;190(1-2):165-9. Epub 2007 Sep 21.

PMID:
17889376
16.

Concurrent validity of the WISC-IV in eligibility decisions for students with educable mental disabilities.

Launey KB, Carroll J, Van Horn KR.

Psychol Rep. 2007 Jun;100(3 Pt 2):1165-70.

PMID:
17886504
17.

Evaluation and comparison of two Stuart's liquid swab transport systems tested by the CLSI M40 method.

Van Horn KG, Rankin I.

Eur J Clin Microbiol Infect Dis. 2007 Aug;26(8):583-6.

PMID:
17564731
18.

Estrogen-triggered delays in mammary gland gene expression during the estrous cycle: evidence for a novel timing system.

Silberstein GB, Van Horn K, Hrabeta-Robinson E, Compton J.

J Endocrinol. 2006 Aug;190(2):225-39.

19.

Evaluation of antibiotic combinations against multidrug-resistant Acinetobacter baumannii using the E-test.

Haddad FA, Van Horn K, Carbonaro C, Aguero-Rosenfeld M, Wormser GP.

Eur J Clin Microbiol Infect Dis. 2005 Aug;24(8):577-9. No abstract available.

PMID:
16133416
20.

Dealing with meal plan blahs.

Van Horn K.

Diabetes Self Manag. 2003 Mar-Apr;20(2):65-6, 68, 72-5. No abstract available.

PMID:
12715736
Items per page

Supplemental Content

Loading ...
Write to the Help Desk